Genetically modified pig-to-baboon liver xenotransplantation demonstrates survival beyond 4 weeks as a bridge therapy for acute liver failure.
Xenotransplantation research must carefully balance scientific progress with ethical considerations, favoring academic and government oversight over commercial dominance.
Regulatory frameworks, including expert committees, are critical to ensure patient safety and equitable clinical implementation.
Public opinion studies reveal broad acceptance of xenotransplantation across diverse populations, emphasizing need to focus on research direction and regulation rather than societal hesitation.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
